Status:
UNKNOWN
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
Lead Sponsor:
Hellenic Oncology Research Group
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of his study is to investigate the intra tumor heterogeneity of the primary tumor and the involved lymph nodes from patients with resectable NSCLC, to detect primary tumor genetic alternat...
Detailed Description
Lung cancer is the most common cancer in the world. In operable early stage patients NSCLS can be curable, but even after complete primary tumor resection, about 45% of early stage patients develop lo...
Eligibility Criteria
Inclusion
- Histologically confirmed NSCLC (adenocarcinoma and squamous cell carcinoma).
- Age ≥ 18 years
- Operable (stages I-IIIA) NSCLC
- Patients with signed written informed consent obtained according to local guidelines
Exclusion
- Patients \< 18 years
- Patients with non operable NSCLC (regardless of disease stage)
- Patients who have any current or prior medical condition that may interfere with the conduct of the study or the evaluation of its results in the opinion of the Investigator
Key Trial Info
Start Date :
January 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03771404
Start Date
January 5 2018
End Date
December 1 2021
Last Update
December 11 2018
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Pneumological Dept, GNA "Sotiria"
Athens, Attica, Greece, 11527
2
7th Pneumological Dept, GNA "Sotiria"
Athens, Attica, Greece, 11527
3
Thoracic Surgery Dept, GNA "Sotiria"
Athens, Attica, Greece, 11527
4
Thoracic Surgery Clinic, "Hygeia" Hospital
Athens, Attica, Greece, 15123